JAGSNPHARM

Jagsonpal Pharmaceuticals Limited

Healthcare · BOTH

Thu, 25 Jun, 2026
- Filing
  Jagsonpal Pharmaceuticals informed the exchange of a change in director(s), with no further details provided on the app…
  NSE ↗
- Filing
  Jagsonpal Pharmaceuticals appoints an independent director
  NSE ↗
- Filing
  Mr. Anil Kumar Matai appointed as additional Non-Executive Independent Director
  BSE ↗
Thu, 4 Jun, 2026
- Filing
  Routine ESOP allotment notification
  NSE ↗
Wed, 3 Jun, 2026
- Filing
  SEBI Takeover Regulations Regulation 31(4) disclosure filed today
  NSE ↗
Tue, 2 Jun, 2026
- Filing
  Buy-back program closure announced with effective date Jun 02, 2026
  NSE ↗
- Filing
  Buyback closure and share extinguishment announced
  BSE ↗
Mon, 1 Jun, 2026
- News
  Quarterly results announcement filed
  livemint.com ↗
Mon, 25 May, 2026
- Filing
  Post-buyback announcement filed one day ago
  BSE ↗
Thu, 21 May, 2026
- Filing
  Resignation of director filed 3 days ago
  NSE ↗
- Filing
  Resignation of a director disclosed but no identity, reason, or replacement announced
  NSE ↗
- Filing
  Independent director resignation effective May 18, 2026
  NSE ↗
- Filing
  Routine Regulation 30 disclosure of independent director resignation without disclosed circumstances or succession plan…
  BSE ↗

Get JAGSNPHARM on your morning brief.

A calm daily reading of the filings on the stocks you actually hold — cited, no tips.